Yahoo! Canada Finance: Drug Manufacturers Industry News

Departure of Mr. Mark Redmond, Ph.D. as President & CEO of CEAPRO

Fri, 04 Jul 2008 19:00:14 GMT

Marketwire - Ceapro Inc. (TSX VENTURE:CZO) The Company regrets to inform shareholders that Mr. Mark Redmond, Ph.D...

Mindray Announces 20-F Filing

Fri, 04 Jul 2008 12:00:10 GMT

PRNewswire - Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced it has filed its annual report on Form 20-F, including its audited financial statements for the fiscal year ended December 31, 2007, with the U.S.

Shire Ltd - Second Quarter 2008 Results Date Notification - 31 July 2008

Fri, 04 Jul 2008 11:00:25 GMT

PRNewswire - Shire Limited (LSE:SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, will announce second quarter 2008 earnings on Thursday 31 July 2008

California Pharmacies Expect Disaster after Loss in Lawsuit Loss to Stop the 10 Percent Medi-Cal Provider Cuts

Fri, 04 Jul 2008 00:32:20 GMT

Business Wire - Today, a state court denied eight retail pharmacies’ motion to stop the ten percent Medi-Cal provider cuts.

Ferro Corporation Announces Pricing for Tender Offer and Consent Solicitation

Thu, 03 Jul 2008 21:54:34 GMT

Business Wire - Ferro Corporation (NYSE: FOE) ("the Company"), today announced the tender offer consideration and the total consideration to be paid in connection with the offer to purchase all of its outstanding 9 1/8% Senior Notes due in January 2009 (the "Notes") being conducted pursuant to the terms of and subject to the conditions in the Offer to Purchase and Consent Solicitation Statement and the related Letter of Transmittal, each dated June 20, 2008 (the “Offer to Purchase”).

Bentley Pharmaceuticals & Teva Pharmaceutical Industries Ltd. Merger Consideration Established at $14.82 Per Share

Thu, 03 Jul 2008 21:31:02 GMT

Business Wire - Bentley Pharmaceuticals, Inc. (“Bentley”) (NYSE: BNT) announced that the aggregate cash purchase price for its acquisition by Teva Pharmaceutical Industries Ltd. (“Teva”) has been adjusted in accordance with the merger agreement after completion of the previously announced taxable spin-off of its drug delivery business, CPEX Pharmaceuticals, Inc. (“CPEX”)(NASDAQ: CPEX).

Introgen Reduces Development Staff to Focus on Commercial Activities after ADVEXIN Regulatory Filings in U.S. and Europe

Thu, 03 Jul 2008 21:30:17 GMT

Business Wire - Introgen Therapeutics, Inc. (NASDAQ:INGN) today announced a re-allocation of employees to focus on regulatory review and commercial activities.

Grubb & Ellis Healthcare REIT Acquires Medical Portfolio 2

Thu, 03 Jul 2008 20:46:20 GMT

PRNewswire - Grubb & Ellis Healthcare REIT, Inc. today announced the acquisition of Medical Portfolio 2. The...

Please kill this story.

Thu, 03 Jul 2008 20:38:17 GMT

Business Wire - B. Braun Medical Inc. requests that their press release BW5079, issued July 2, 2008, entitled...

Immunotec announces new Chief Operating Officer

Thu, 03 Jul 2008 20:14:38 GMT

CNW Group - Immunotec Inc. (TSX-V :IMM) today announced the appointment of Daniel L. Murphy as Executive Vice President...

Grubb & Ellis Healthcare REIT Acquires Renaissance Medical Centre in Bountiful, Utah

Thu, 03 Jul 2008 19:48:20 GMT

PRNewswire - Grubb & Ellis Healthcare REIT, Inc. today announced the acquisition of Renaissance Medical Centre, a five- story, Class A medical office building located in the Salt Lake City suburb of Bountiful, Utah.

Savient Announces U.S. Court of Appeals Affirmation of the Dismissal of Securities Class Action Complaint

Thu, 03 Jul 2008 19:43:25 GMT

Business Wire - Savient Pharmaceuticals, Inc. (NASDAQ:SVNT) today announced that the United States Court of Appeals for the Third Circuit has entered a Judgment affirming the decision of the U.S.

Enfora to Demonstrate Wireless Patient Monitoring Solutions at Healthcare Unbound

Thu, 03 Jul 2008 19:25:21 GMT

Business Wire - Enfora, a leading global supplier of intelligent wireless networking solutions, will present and demonstrate several advanced patient monitoring solutions at Healthcare Unbound, an industry conference focused on the convergence of consumer and healthcare technologies, and scheduled for July 7 and 8 at the San Francisco Marriott.

Fluxion Biosciences Wins R&D 100 Award

Thu, 03 Jul 2008 18:21:22 GMT

Business Wire - Fluxion Biosciences, a leading provider of functional cell biology systems for life science research and drug discovery, today announced that it has won a 2008 R&D 100 Award for its BioFlux™ 200 System.

Medivation to Host Conference Call at 5 p.m. EDT Monday to Discuss Top-Line Phase 2 Study Results in Huntington's Disease

Thu, 03 Jul 2008 18:14:34 GMT

PRNewswire - Medivation, Inc. (Nasdaq: MDVN) today announced that it will hold a teleconference at 5:00 p.m. EDT...

Bio-Bridge Science Announces $2.775 Million Private Placement

Thu, 03 Jul 2008 17:58:24 GMT

Business Wire - Bio-Bridge Science, Inc. (OTCBB:BGES), a biotechnology company engaged in the commercial development of vaccines for the prevention and treatment of human infectious diseases announced today that it had closed a private placement of its investment units.

Opsens announces 376% sales growth for third quarter 2008

Thu, 03 Jul 2008 17:49:42 GMT

CNW Group - Opsens Inc. (TSX VENTURE EXCHANGE: OPS) ("Opsens") has released its quarterly financial results for the three and nine-month periods ended May 31, 2008.

Bioheart, Inc., Board Appoints Howard J. Leonhardt Chief Executive Officer

Thu, 03 Jul 2008 17:05:18 GMT

PRNewswire - Bioheart, Inc., (Nasdaq: BHRT) a biotechnology company that is focused on the development of autologous (patient-derived) cell therapies and devices for the treatment of chronic and acute heart damage, today announced that its Board of Directors appointed Howard J. Leonhardt, Bioheart's co-founder, Chairman of the Board and Chief Technology Officer, to serve as Chief Executive Officer effective as of July 1, 2008.

Wyeth and Progenics Receive Approval from European Commission for RELISTOR for Opioid-Induced Constipation in Advanced Illness Patients

Thu, 03 Jul 2008 16:57:26 GMT

Business Wire - Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), and Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX), today announced that the companies have received marketing approval for RELISTOR™ (methylnaltrexone bromide) subcutaneous injection from the European Commission.

Vibra Healthcare Acquires two Hospitals in Southern California

Thu, 03 Jul 2008 16:51:31 GMT

PRNewswire - Vibra Healthcare, LLC ("Vibra") announced today that it has completed the acquisition of two specialty hospitals in Southern California.

Medicago Receives Contribution From NRC-IRAP for Seasonal Flu Vaccine Program

Thu, 03 Jul 2008 16:49:14 GMT

Marketwire - Medicago Inc. (TSX VENTURE:MDG) today announced it has been awarded a non-refundable contribution of up to $279,700 from Canada's National Research Council Industrial Research Assistance Program ("NRC-IRAP") to support the development of the Company's seasonal influenza Virus-Like Particles (VLP) vaccine program.

Cell Biosciences Strengthens Management Team

Thu, 03 Jul 2008 16:48:46 GMT

PRNewswire - Cell Biosciences, Inc., a provider of ultrasensitive protein detection and characterization systems to life science researchers, today announced three key management team additions.

Non-Prescription, Replens Long-Lasting Vaginal Moisturizer(R) Instant Relief for Feminine Dryness as Effective as Popular Hormone Therapy Number One A

Thu, 03 Jul 2008 16:23:18 GMT

Business Wire - Pharmacy Post has named Replens Long Lasting Vaginal Moisturizer® the number one recommended product in the vaginal lubricant and moisturizer market in their annual “Over the Counter Market Report.”

Within3 Taps Thought Leader User Group at the Case Western Reserve University School of Medicine

Thu, 03 Jul 2008 16:07:24 GMT

Business Wire - Within3 announced it is initiating a “Thought Leader Program” by tapping health care professionals and scientists from the Case Western Reserve University School of Medicine Alumni and Faculty to advise the online professional network on its upcoming Version 2.0 release of its technology.

Cellectis and Regeneron Sign an Agreement Over the use of Homologous Recombination Technology

Thu, 03 Jul 2008 16:00:49 GMT

CNW Group - Cellectis SA today announced the signature of an agreement with Regeneron Pharmaceuticals, Inc. over the use of Cellectis' patents covering certain uses of homologous recombination for the generation of innovative human therapies, including the development of fully human monoclonal antibodies.

CVS/pharmacy Delivers Disaster Relief in Iowa Communities Impacted by Recent Flooding

Thu, 03 Jul 2008 15:45:02 GMT

PRNewswire - The CVS Caremark Charitable Trust, the private foundation managed by CVS Caremark, announced today that it has donated $100,000 to the American Red Cross for disaster relief efforts throughout the more than 80 counties in Iowa declared federal or state disaster areas due to recent storms, tornadoes and flooding.

Mergent, Inc. Announces Changes to the HealthShares(TM) Ophthalmology Index

Thu, 03 Jul 2008 15:44:15 GMT

PRNewswire - Mergent, Inc., administrator for the HealthShares(TM) Indexes, a series of 20 underlying indexes for the HealthShares(TM) Exchange Traded Funds, today announced the following change effective on the opening of trading on Wednesday July 9, 2008: ISTA Pharmaceuticals (Nasdaq: ISTA) will replace Jerini AG (Frankfurt, Germany: JI4) in the HealthShares(TM) Ophthalmology Index.

Remarks by the President at Ceremonial Groundbreaking of Walter Reed National Military Medical Center

Thu, 03 Jul 2008 15:16:17 GMT

Business Wire - Walter Reed National Naval Medical Center

Getinge Announces Date Of 2008 Q2 Report and Conference Call

Thu, 03 Jul 2008 15:13:18 GMT

Business Wire - Regulatory News:

DOT Therapy: Newest Breakthrough Technology in Laser Skin Resurfacing

Thu, 03 Jul 2008 14:57:16 GMT

PRNewswire - Laugh lines, crow's feet, brown spots, and wrinkles are inevitable signs of aging, but all that is about to change thanks to the most advanced technology in laser skin resurfacing.

Algorithme Pharma buys clinical pharmacology research unit in Baltimore

Thu, 03 Jul 2008 14:35:00 GMT

The Canadian Press - LAVAL, Que. - Algorithme Pharma, a private Montreal-area drug development services company, has acquired new clinical research centre in Baltimore, Md., a move that helps the company get closer to its U.S. customers.

Made in America: Sound Surgical Technologies Brings Disposable Product Manufacturing Back to the USA

Thu, 03 Jul 2008 14:28:20 GMT

Business Wire - Sound Surgical Technologies LLC, developer of the VASER® Lipo System, announced that as of today all disposable products will be designed and manufactured in the United States.

Palomar Medical Technologies to Manage Supplier Quality with Pilgrim's Supplier Focus(TM)

Thu, 03 Jul 2008 14:26:38 GMT

Business Wire - Pilgrim Software, Inc., a world-leading provider of Enterprise Compliance and Quality Management (ECQM) software solutions, today announced that Palomar Medical Technologies, a manufacturer of light-based products used in medical and cosmetic procedures, has selected and rapidly implemented Pilgrim’s Supplier Focus™ software to automate its supplier quality management system.

Barr Will Host an Earnings Conference Call on August 7, 2008 to Discuss the Results for the Second Quarter of Calendar 2008

Thu, 03 Jul 2008 14:10:15 GMT

PRNewswire - Barr Pharmaceuticals, Inc. (NYSE: BRL) today announced that the Company will host a Conference Call at 8:30AM Eastern time on Thursday, August 7 to discuss earnings results for the second quarter of calendar 2008, ended June 30, 2008.

Today's Caregiver Magazine Celebrates 70th Fearless Caregiver Conference with Free Tickets to Boynton Event

Thu, 03 Jul 2008 14:03:06 GMT

Business Wire - Today's Caregiver magazine announced today that it will make available a limited number of tickets for family caregivers to attend the Palm Beach Fearless Caregiver Conference on July 16th at Benvenuto's in Boynton Beach.

/R E P E A T - Algorithme Pharma Gains U.S. Footing in Baltimore, Through Acquisition of Clinical Pharmacology Research Unit Owned by BASi, Bioanalyti

Thu, 03 Jul 2008 14:02:29 GMT

CNW Group - For the very first time in its history, the Laval- based firm Algorithme Pharma, which already has many U.S. clients, has achieved its goal of locating in the U.S., through its acquisition of a new clinical research centre in Baltimore, Maryland.

The Institut de la Vision and Iris Pharma Join Forces to Strengthen the Bond between the Private and Public Sectors, and between Industry and Academic

Thu, 03 Jul 2008 14:02:05 GMT

Business Wire - The Institut de la Vision, a research center exclusively dedicated to eye diseases, has been the industry's benchmark on vision-related issues since its opening in March 2008.

PerkinElmer Second Quarter Earnings and Conference Call Notification

Thu, 03 Jul 2008 14:01:42 GMT

Business Wire - PerkinElmer, Inc. (NYSE: PKI) today announced that on Thursday, July 24, 2008, after market close, the Company will release second quarter 2008 results.

Rising Medical Solutions, Inc. Expands Its California Managed Care Services to Include Utilization Review Program

Thu, 03 Jul 2008 14:00:16 GMT

PRNewswire - Rising Medical Solutions, Inc. (Rising), a leading medical cost containment and care management organization, has extended its offerings in California to include Utilization Review (UR) services in addition to its Medical Bill Review and Medical Provider Network (MPN) services in the State.

Vasogen stops spending on neuroinflammatory drugs to preserve cash

Thu, 03 Jul 2008 13:55:00 GMT

The Canadian Press - MISSISSAUGA, Ont. - Vasogen Inc. (TSX:VAS) is halting spending on a series of drugs including one aimed at Lou Gehrig's disease as it struggles to preserve cash while "exploring strategic alternatives."

Seven Major U.S. Cancer Institutions Order Hyperthermia Systems from BSD Medical

Thu, 03 Jul 2008 13:33:23 GMT

Business Wire - BSD Medical Corp. (NASDAQ:BSDM) today announced the addition of seven new BSD-500 hyperthermia systems purchased by major cancer treatment center in the United States.

Advanced Life Sciences Added to Russell Microcap Index

Thu, 03 Jul 2008 13:31:14 GMT

PRNewswire - Advanced Life Sciences Holdings, Inc. (Nasdaq: ADLS), a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, cancer and respiratory diseases, today announced that it was added to the Russell Microcap(R) Index after the Russell Investment Group reconstituted its comprehensive set of U.S. and global equity indexes on June 27, 2008.

Senetek Announces Termination of Invicorp(R) License Agreement With Ardana Bioscience Limited

Thu, 03 Jul 2008 13:30:14 GMT

PRNewswire - Senetek PLC (OTC Bulletin Board: SNKTY), a Life Sciences company engaged in the development of technologies that target the science of healthy aging, today announced termination of the Invicorp(R) License Agreement with Ardana Bioscience Limited ("Ardana").

Zynex Announces Increased Orders in June

Thu, 03 Jul 2008 13:15:53 GMT

Business Wire - Zynex Medical Holdings, Inc. (OTCBB:ZYNX), a provider of pain management systems and electrotherapy products for medical patients with functional disability, announces an increase in its orders of 171% for June of 2008 compared to the same month last year.

Learn about Cough and Throat Remedies in the United States 2008

Thu, 03 Jul 2008 13:01:36 GMT

Business Wire - Research and Markets (http://www.researchandmarkets.com/resea rch/c1fc69/cough_and_throat_r) has announced the addition of the "Cough and Throat Remedies in the United States 2008" report to their offering.

Vasogen Provides Corporate Update

Thu, 03 Jul 2008 13:01:35 GMT

CNW Group - Vasogen Inc. (NASDAQ:VSGN; TSX:VAS) today announced that it has implemented additional restructuring plans to further reduce its cash burn rate.

Advitech announces positive clinical and pre-clinical results

Thu, 03 Jul 2008 13:01:34 GMT

CNW Group - Advitech Inc. ("Advitech" or the "Company") (TSX Venture Exchange: AVI) announces today positive results from its clinical trials on psoriasis, eczema and pre-clinical program on wound healing.

Triple-S Management Corporation Schedules Second-Quarter Earnings Release and Webcast

Thu, 03 Jul 2008 13:00:31 GMT

PRNewswire - Triple-S Management Corporation (NYSE: GTS) today announced that the Company plans to release financial results for the second quarter ended June 30, 2008, before the market opens on August 5, 2008.

Rosetta Genomics to Present at Collins Stewart Fourth Annual Growth Conference

Thu, 03 Jul 2008 12:30:30 GMT

PRNewswire - Rosetta Genomics Ltd (Nasdaq: ROSG), a leading developer of microRNA-based diagnostics and therapeutics, announced today it will present Collins Stewart Fourth Annual Growth Conference on Wednesday, July 9, at 8:30 am EST at the Mandarin Oriental Hotel in New York.

Huifeng Bio-Pharmaceutical (HFGB) Information to Be Available Through Standard & Poor's Market Access Program

Thu, 03 Jul 2008 12:30:14 GMT

PRNewswire - Huifeng Bio-Pharmaceutical Technology, Inc. (OTC Bulletin Board: HFGB), a leading developer and producer of plant extracts and pharmaceutical raw materials for use in pharmaceutical, nutraceutical and food production in China, announced today that its company information will be made available via Standard & Poor's Market Access Program, an information distribution service that enables subscribing publicly traded companies to have their company information disseminated to users of Standard & Poor's Advisor Insight.

Senesco Signs a Supply Agreement for Polyplus-transfection's Delivery System

Thu, 03 Jul 2008 12:15:15 GMT

PRNewswire - Senesco Technologies, Inc. ("Senesco" or the "Company") (Amex: SNT) announced today that it has contracted with Polyplus-transfection (Illkirch, France) to supply Polyplus's "in vivo-jetPEI" for systemic delivery of Senesco's combination therapy of siRNA against Factor 5A and a plasmid of the Factor 5A gene.

OSI Pharmaceuticals Announces Conversion Period for Convertible Notes

Thu, 03 Jul 2008 12:04:18 GMT

Business Wire - OSI Pharmaceuticals, Inc. (Nasdaq: OSIP) announced today that its 2% Convertible Senior Notes due 2025 (the “notes”) are now convertible at the option of the holders and will remain convertible through September 30, 2008, the last trading day of the current fiscal quarter, as provided for in the Indenture governing the notes.

OncoGenex increases economic interest in lead cancer drug OGX-011

Thu, 03 Jul 2008 12:03:28 GMT

CNW Group - OncoGenex Technologies Inc. and Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced today that the companies have amended their agreement and OncoGenex has elected to independently develop its lead cancer drug OGX-011.

Allos Therapeutics to Present at the Collins Stewart Fourth Annual Growth Conference

Thu, 03 Jul 2008 12:01:51 GMT

Business Wire - Allos Therapeutics, Inc. (NASDAQ: ALTH), a biopharmaceutical company focused on developing and commercializing innovative small molecule drugs for the treatment of cancer, today announced that members of the Company’s senior management will present a corporate overview at the Collins Stewart Fourth Annual Growth Conference in New York.

APP Pharmaceuticals Receives Final Approvals for Additional Dosages of Granisetron Hydrochloride Injection, USP

Thu, 03 Jul 2008 12:01:29 GMT

Business Wire - APP Pharmaceuticals, Inc. (Nasdaq:APPX), a leading manufacturer of multi-source and branded injectable pharmaceutical products, today announced that it has received final approvals from the U.S.